Erratum: Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation (Biochemical and Biophysical Research Communications (2004) 323 (782-788) PII: S0006-291X(04)01938-2 and DOI: 10.1016/j.bbrc.2004.08.151);Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation

Biochemical and Biophysical Research Communications

Volumn 323, Issue 3, 2004, Pages 782-788

  Hirakata, Masao ^a   Tozawa, Ryuichi ^a   Imura, Yoshimi ^a   Sugiyama, Yasuo ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Cholesterol; Cholesteryl ester; Pioglitazone; Rosiglitazone; THP 1 derived macrophages

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; ROSIGLITAZONE;

ARTICLE; CELL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 4544274010     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.051     Document Type: Erratum

References (26)

1. F.M. Martens, F.L. Visseren, J. Lemay, E.J. de Koning, and T.J. Rabelink Metabolic and additional vascular effects of thiazolidinediones Drugs 62 2002 1463 1480
2. G. Chinetti, S. Griglio, M. Autonucci, I.P. Torra, P. Delerive, and Z. Majd Activation of peroxisome proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages J. Biol. Chem. 273 1998 25573 25580
3. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 391 1998 79 82
4. C. Jiang, A.T. Ting, and B. Seed PPARγ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
5. L. Nagy, P. Tontonoz, J.G.A. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell 93 1998 229 240
6. P. Tontonoz, L. Nagy, J.G.A. Alvarez, V.A. Thomazy, and R.M. Evans PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
7. K.J. Moore, E.D. Rosen, M.L. Fitzgerald, F. Randow, L.P. Andersson, D. Altshuler, D.S. Milstone, R.M. Mortensen, B.M. Spiegelman, and M.W. Freeman The role of PPAR-γ in macrophage differentiation and cholesterol uptake Nat. Med. 7 2001 41 47
8. M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 105 2000 1049 1056
9. G. Larigauderie, C. Furman, M. Jaye, C. Lasselin, C. Copin, J.C. Fruchart, G. Castro, and M. Rouis Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis Arterioscler. Thromb. Vasc. Biol. 24 2004 504 510
10. C. Buechler, M. Ritter, C.Q. Duong, E. Orso, M. Kapinsky, and G. Schmitz Adipophilin is a sensitive marker for lipid loading in human blood monocytes Biochim. Biophys. Acta 1532 2001 97 104
11. T. Langmann, J. Klucken, M. Reil, G. Liebisch, M.F. Luciani, G. Chimini, W.E. Kaminski, and G. Schmitz Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages Biochem. Biophys. Res. Commun. 257 1999 29 33
12. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, R.M. Evans, and P. Tontonoz A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol. Cell 7 2001 161 171
13. G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, I.P. Torra, E. Teissier, A. Minnich, M. Jaye, N. Duverger, H.B. Brewer, J.C. Fruchart, V. Clavey, and B. Staels PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat. Med. 7 2001 53 58
14. L. Patel, S.J. Charlton, I.C. Marshall, G.B. Moore, P. Coxon, K. Moores, J.C. Clapham, S.J. Newman, S.A. Smith, and C.H. Macphee PPARγ is not a critical mediator of primary monocyte differentiation or foam cell formation Biochem. Biophys. Res. Commun. 290 2002 707 712
15. M.S. Brown, Y.K. Ho, and J.L. Goldstein The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters J. Biol. Chem. 255 1980 9344 9352
16. I. Ishii, M. Oka, N. Katto, K. Shirai, Y. Saito, and S. Hirose β-VLDL-induced cholesterol ester deposition in macrophages may be regulated by neutral cholesterol esterase activity Arterioscler. Thromb. 12 1992 1139 1145
17. S. Ghosh, and R. Natarajan Cloning of the human cholesteryl ester hydrolase promoter: identification of functional peroxisomal proliferator-activated receptor responsive elements Biochem. Biophys. Res. Commun. 284 2001 1065 1070
18. K. Maung, A. Miyazaki, H. Nomiyama, C.C. Chang, T.Y. Chang, and S. Horiuchi Induction of acyl-coenzyme A: cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D(3) or 9-cis-retinoic acid in undifferentiated THP-1 cells J. Lipid Res. 42 2001 181 187
19. C.A. Argmann, C.G. Sawyez, C.J. McNeil, R.A. Hegele, and M.W. Huff Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins Arterioscler. Thromb. Vasc. Biol. 23 2003 475 482
20. G. Chinetti, S. Lestavel, J.C. Fruchart, V. Clavey, and B. Staels Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages Circ. Res. 92 2003 212 217
21. S. Rosenblatt, B. Miskin, N.B. Glazer, M.J. Prince, and K.E. Robertson The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus Coron. Artery Dis. 12 2001 413 423
22. J. Sakamoto, H. Kimura, S. Moriyama, H. Odaka, Y. Momose, Y. Sugiyama, and H. Sawada Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone Biochem. Biophys. Res. Commun. 278 2000 704 711
23. J.L. Goldstein, S.K. Basu, and M.S. Brown Receptor-mediated endocytosis of low-density lipoprotein in cultured cells Methods Enzymol. 98 1983 241 260
24. A. Rodriguez, S.D. Kafonek, A. Georgopoulos, and P.S. Bachorik Cell density can affect cholesteryl ester accumulation in the human THP-1 macrophage J. Lipid Res. 35 1994 1909 1917
25. K. Budde, H.H. Neumayer, L. Fritsche, W. Sulowicz, T. Stompor, and D. Eckland The pharmacokinetics of pioglitazone in patients with impaired renal function Br. J. Clin. Pharmacol. 55 2003 368 374
26. A.K. Miller, A.M. Inglis, K.T. Culkin, D.K. Jorkasky, and M.I. Freed The effect of acarbose on the pharmacokinetics of rosiglitazone Eur. J. Clin. Pharmacol. 57 2001 105 109